Nexstim announced the completion of a reverse stock split at a ratio of 1:30 in order to improve trading conditions. We therefore adjust our target price in line with the share consolidation and continue to believe that the shares represent an asymmetric risk profile considering current trading levels. In our view, the diagnostics segment represents a solid valuation floor with limited downside risk and potential for market expansion. The recent signing of the distribution agreement with Ampere ....
28 Nov 2018
Reverse stock split to improve trading conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Reverse stock split to improve trading conditions
Nexstim announced the completion of a reverse stock split at a ratio of 1:30 in order to improve trading conditions. We therefore adjust our target price in line with the share consolidation and continue to believe that the shares represent an asymmetric risk profile considering current trading levels. In our view, the diagnostics segment represents a solid valuation floor with limited downside risk and potential for market expansion. The recent signing of the distribution agreement with Ampere ....